Adjusted estimates for time-to-event endpoints

Overview of attention for article published in Lifetime Data Analysis, September 2008

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#14 of 124)

Mentioned by

policy: 1 policy source

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma : Final appraisal determination committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 24 Sep 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.